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Summary Eighty-four patients with breast cancer at high risk of bone metastases were investigated with
magnetic resonance imaging (MRI) of the thoracolumbar spine. Of 58 patients with normal limited skeletal
surveys (LSS) and bone scans (BS), 4 (7%) had MR images compatible with malignant infiltration. Fourteen
patients had abnormal bone scans with normal or non-diagnostic plain films; 7 of these patients (50%) had
MR images compatible with malignant infiltration. Twelve patients had single or multiple wedge collapses of
uncertain aetiology on plain film; MR demonstrated metastatic disease as the cause of wedge collapse in 7
(58%). MRI may define a group of patients with extra-osseous relapse who have occult metastatic disease.
Although the detection rate in patients with primary breast cancer is low (4/45), MRI is of value in
determining the cause of wedge collapse in postmenopausal women with breast cancer and may elucidate the
cause of an abnormal bone scan with normal or non-diagnostic plain films.
The skeletal system is the commonest site of metastases in
patients with breast cancer (Kamby et al., 1987) and micro-
metastases in bone marrow may be detected on aspiration or
trephination, using an immunocytochemical tumour cell
antibody technique, in 9-20% of patients with breast cancer
who have no other evidence of metastatic disease (Mansi et
al., 1987; Redding et al., 1983). The detection of skeletal
micrometastases at initial presentation is of prognostic
significance and may alter primary management (Coombes et
al., 1986). The presence of micrometastases has been shown
to correlate with other features suggesting a poor prognosis
such as T status, axillary nodal status, vascular invasion and
pathological size of the primary tumour (Friedell et al., 1965;
Fisher et al., 1969; Fisher et al., 1970), and may predict for
the early development of overt skeletal metastases (Mansi et
al., 1987).
X-ray and isotope bone scanning are commonly used to
detect skeletal metastases. Plain films require at least 50%
cortical bone loss before abnormalities are seen (Edelstyn et
al., 1967). Wedge collapse of vertebrae on plain films can
pose diagnostic problems in a population of postmenopausal
women. Bone scans are sensitive but not specific and may be
negative if there is destruction by gross lytic disease (Galasko
et al., 1972). Although bone marrow aspiration may provide
a more sensitive method for detecting micrometastases, it is
an invasive procedure and the identification of malignant
cells by immunocytochemical technique is time-consuming
(Coombes et al., 1986).
Magnetic resonance imaging (MRI), a non-invasive techni-
que, may have a higher sensitivity for the detection of
skeletal metastases (Daffner et al., 1986; Smoker et al., 1987;
Godersky et al., 1987) than X-ray or isotope bone scan. MRI
has been used in the assessment of spinal cord disease and
can identify the presence of bone marrow metastases and
spinal cord compression (Williams et al., 1989). Daffner et al.
(1986) had no false positives or false negatives when MRI
was correlated with other techniques. We have examined this
method for the detection of occult bone metastases in the
vertebral column ofpatients with breast cancer at the time of
primary diagnosis and at extra-osseous relapse.
Patients and methods
Patients with primary, or non-osseous, breast cancer who
were considered at high risk of skeletal metastases were
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referred for MRI if plain films and bone scans were normal
or non-diagnostic. Patients at initial diagnosis were judged at
high risk if their tumours were greater than 5 cm at clinical
assessment, or they had vascular invasion and/or histo-
logically positive axillary nodes (high risk primary). Patients
were also regarded at high risk of skeletal metastases at first
or subsequent extra-osseous relapse.
All patients were assessed with full blood count, serum
biochemistry, chest X-ray, limited skeletal survey (LSS), bone
scan (BS) and liver ultrasound before MRI. Patients were not
on systemic treatment for breast cancer during their assess-
ment.
MRI was done with a Siemens Magnetom operating at 1.5
Tesla. TI-weighted images of the entire thoracic and lumbar
spine were taken in the sagittal plane using 5 mm thick
sections with 2.5 mm interslice gap. An 18 cm elliptical spine
coil was used for all investigations. Seven sections were
obtained as a multisection acquisition of each region. A spin
echo technique was used with a repetition time of 0.5 s and
an echo time of 17 x 1-0 s. The total time involved for each
patient, including setting up and imaging, was approximately
30 minutes. MR was positive when there was focal decrease
in signal intensity within the bone marrow in the vertebral
column.
The MRI images were reported by one of two radiologists.
If a positive result was obtained with MRI the plain films
were reviewed retrospectively to exclude 'missed' disease. On
bone scan, the entire skeleton was assessed for metastatic
disease and reported as normal or with some areas of in-
creased uptake which were not suspicious for metastatic
disease. Bone scans were not reviewed retrospectively.
Results
The results of isotope bone scan, X-ray of the vertebral
column (LSS) and MRI are shown in the Table.
Forty-five patients were classified as high risk primary
patients. Forty-one of these patients had normal LSS and BS
and of these 4 (9.8%) had abnormal MR images (Figure 1).
On retrospective review, one of these patients had an abnor-
mality on plain film at the corresponding site. Four high risk
primary patients had nonspecific abnormalities on BS with
normal LSS and MR images. Overall abnormal MR images
were seen in 8.8% of the 45 high risk primary patients.
Thirty-nine patients with extra osseous relapse were
studied. Seventeen patients had normal LSS and BS and, of
these, one patient had an abnormal MR image. A further 10
patients had increased nonspecific uptake on BS but no plain
film correlation to suggest metastases. Seven of these 10
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Table I MRI findings in relation to bone scan (BS) and plain films
(LSS)
MRI findings
Patient status Abnormal Normal Total
Normal LSS and BS
High risk primary 4a 37 41
Relapse 1 16 17
Total 5 53 58
Abnormal BS
High risk primary 0 4 4
Relapse 7 3 10
Total 7 7 14
Wedge collapse
Normal BS 1 3 4
Abnormal BS 6 2 8
Total 7 5 12
aOne had an abnormal LSS on retrospective review.
Figure 1 Sagittal T-1 weighted CTR 50 msec TE (7 msec) image
of the lumber spine showing focal areas of reduced signal inten-
sity within the vertebral marrow in a patient with primary breast
cancer (normal LSS + BS).
patients had MR images indicative of metastases. Follow up
at 12 to 18 months on patients with abnormal BS are
thought to relate to degenerative change.
Twelve patients had single or multiple wedge collapse of
thoracic and/or lumbar vertebrae on plain film. An example
is shown in Figure 2. These features were not diagnostic of
malignant infiltration and could have been related to
osteoporotic collapse. There were nonspecific abnormalities
on BS in 8 of these patients. MRI demonstrated reduced
signal intensity indicating malignant infiltration in 7 patients
(6 with abnormal BS and I with normal BS). Asymptomatic
spinal cord compression at the site ofcollapse was found in 2
patients (Figure 3).
Discussion
Normal bone marrow gives a high intensity signal on MRI
due to its fat content but, when normal fatty marrow is
infiltrated by tumour, there is a focal decrease in signal
intensity. This is in contrast to the focal areas of high
intensity due to fatty infiltration seen in normal volunteers
(Hajek et al., 1987). Although MRI is sensitive in the detec-
tion of marrow infiltration by malignant disease (Daffner et
al., 1986; Godersky et al., 1987; Smoker et al., 1987), its
exact role is not defined. T2 weighted images were not used
in this study as they appear to add little to the sensitivity and
specificity in the detection of abnormalities in marrow disease
(Vogler & Murphy, 1989).
Figure 2 a, Lateral plain radiograph of the thoracic spine dem-
onstrates anterior wedging of the vertebral bodies of T7, Tg and
T,1. 2b, The corresponding sagittal T, weighted (TR 50 msec TE
17 msec) MR image of the thoracic spine shows low signal inten-
sity within the vertebral body of T7 consistent with replacement
of the normal fatty marrow by malignancy infiltrate. There is
preservation of the normal high signal intensity of the marrow
with Tg and T, consistent with osteoporotic collapse.
Figure 3 A metastasis is shown at T9 with a soft tissue mass
extending posteriorly causing an extradural spine cord compres-
sion.298 A.L. JONES et al.
The detection of overt metastases in patients with breast
cancer requires systemic rather than local treatment. The
presence of occult metastases could also affect management.
In this study, only 7.5% of high risk primary patients had
abnormal MR images. All these primary patients were elig-
ible for adjuvant therapy (either chemotherapy, or hormones)
and the finding of an abnormal MR image did not affect
subsequent management. The prevalence of MRI-detected
occult metastases is less than the reported incidence of
immunocytochemically detected micrometastases in studies
using multiple bone marrow aspirates (Mansi et al., 1987).
The abnormalities detected on MRI represent more obvious
metastases than those only detected by bone marrow aspira-
tion and may be more important for clinical management.
Older women, with degenerative bone problems, are more
likely to have nonspecific abnormalities on bone scan which
are not always clarified by plain films. These abnormalities
may give rise to diagnostic concern in patients with breast
cancer in whom the possibility of bony relapse may affect
management. One approach to this problem is the use of
computerized tomography which will detect malignant
disease in 50% of these patients (Muindi et al., 1983). In this
study, MRI demonstrated malignant disease in 7 of 14
similar patients with equivocal bone scans. There has been
no evidence of bony relapse in the 7 out of 14 patients with
abnormal BS and normal MRI. A prospective study could
determine the relative value of CT and MRI in this situation.
The presence of collapse of single or multiple vertebrae
may be caused by osteoporosis or metastatic disease. In 7 of
the 12 patients with wedge collapse, MRI demonstrated
malignant disease. This is useful in the management of these
patients both for local control of pain and for the choice of
systemic treatment and assessment of response if there is no
other evidence of metastatic disease. In addition, presympto-
matic cord compression was identified in 2 patients, which
allowed early treatment before clinical evidence of cord com-
pression. BS and MRI showed concordant results in 9/12 and
discordant results in 3/12 patients with wedge collapse. Fol-
low up on the 2 patients with abnormal BS and normal MRI
has shown no evidence ofmetastases at 18 months. Although
a positive bone scan may be indicative of metastatic disease
in patients with wedge collapse further information is neces-
sary to determine management. This may be provided by
MRI.
In summary, in view of the expense and low detection rate,
MRI is not of value in the detection of occult metastases
from breast cancer in high risk patients with primary breast
cancers. Furthermore, it is probably no more sensitive but
more expensive than CT at determining the cause of non-
specific abnormalities on bone scan. However, MRI does
provide useful information about the aetiology of vertebral
wedge collapse and is the investigation of choice for the
imaging of presymptomatic spinal cord compression (Wil-
liams et al., 1989).
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